Fortrea Holdings (MEX:FTRE1) Net Margin %: -3.71% (As of Mar. 2026)


MEX:FTRE1 Fortrea Holdings Inc MEX:FTRE1
66 GF Score
Price MXN435.30
GF Value MXN448.82
! 7 Warning Signs
View Full Analysis

What is Fortrea Holdings Net Margin %?

Fortrea Holdings MEX:FTRE1 66 Net Margin % is -3.71% as of Mar. 2026. GuruFocus rates MEX:FTRE1 with a GF Score™ of 66/100 and a GF Value™ of MXN448.82. The stock has 7 warning signs investors should review. Among 946 Biotechnology companies, Fortrea Holdings ranks better than 63.74% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Fortrea Holdings's Net Income for the three months ended in Mar. 2026 was MXN-426 Mil. Fortrea Holdings's Revenue for the three months ended in Mar. 2026 was MXN11,478 Mil. Therefore, Fortrea Holdings's net margin for the quarter that ended in Mar. 2026 was -3.71%.

The historical rank and industry rank for Fortrea Holdings's Net Margin % or its related term are showing as below:

MEX:FTRE1' s Net Margin % Range Over the Past 10 Years
Min: -36.21   Med: -6.54   Max: 6.56
Current: -16.5

MEX:FTRE1's Net Margin % is ranked better than
63.74% of 946 companies
in the Biotechnology industry
Industry Median: -88.815 vs MEX:FTRE1: -16.50

Fortrea Holdings  (MEX:FTRE1) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Fortrea Holdings Net Margin % Related Terms

Fortrea Holdings Net Margin % Historical Data

* Premium members only.

The historical data trend for Fortrea Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortrea Holdings Net Margin % Chart

Fortrea Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial 3.21 6.56 -0.89 -12.18 -36.21

Fortrea Holdings Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -86.43 -52.78 -2.27 -4.92 -3.71

MEX:FTRE1 vs MAZE, KALV, BCAX: Net Margin % Comparison

For the Biotechnology subindustry, Fortrea Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fortrea Holdings Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fortrea Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Fortrea Holdings's Net Margin % falls into.


MEX:FTRE1
66GF Score
Fortrea Holdings Inc MEX:FTRE1
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fortrea Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Fortrea Holdings's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-17757.221/49036.723
=-36.21 %

Fortrea Holdings's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-425.572/11477.814
=-3.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -3.71% mean?
Fortrea Holdings (MEX:FTRE1) has a Net Margin % of -3.71% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Fortrea Holdings and its competitors. According to the industry distribution chart, Fortrea Holdings ranks #343 out of 946 companies in the Biotechnology industry, placing it in the top 36.3%.
Is Fortrea Holdings' Net Margin % too high?
Fortrea Holdings' current Net Margin % is -3.71%. Based on the distribution chart, Fortrea Holdings ranks #343 out of 946 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Fortrea Holdings has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Fortrea Holdings' Net Margin % compare to MAZE and KALV?
According to the Biotechnology industry distribution chart, Fortrea Holdings ranks #343 out of 946 companies for Net Margin %. This puts Fortrea Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Fortrea Holdings and its competitors. Fortrea Holdings's current Net Margin % is -3.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortrea Holdings stock overvalued right now?
Fortrea Holdings (MEX:FTRE1) has a current Net Margin % of -3.71%. The stock's GF Value™ is MXN448.82, compared to a current price of MXN435.30 — trading 3% below its estimated fair value. The current Net Margin % is -3.71%. Fortrea Holdings' overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Fortrea Holdings (MEX:FTRE1), the current Net Margin % is -3.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortrea Holdings (MEX:FTRE1) Overvalued in 2026?

Based on GuruFocus' analysis, Fortrea Holdings stock appears to be undervalued. The current stock price of MXN435.30 is trading 3% below its estimated GF Value™ of MXN448.82.

Key valuation signals for MEX:FTRE1:

  • Net Margin %: -3.71%
  • GF Value™: MXN448.82 vs. price of MXN435.30 (3% below fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the MEX:FTRE1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortrea Holdings Business Description

Other Exchanges FTRE:USAK67:Germany
Address 8 Moore Drive, Durham, NC, USA, 27713
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
66GF Score

Get the complete analysis for MEX:FTRE1

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN435.30
Price
MXN448.82
GF Value